June 18, 2025
15:00 BST; 10:00 EDT
Duration: 60 minutes
Overview
Join us for an insightful online panel discussion where Prof. Julien Michel of Edinburgh University and Dr Lewis Vidler from Eli Lilly will join Cresset’s Dr Mark Mackey and Dr Mutlu Dogruel to discuss how AI is reshaping small-molecule discovery. This session will cut through the noise around AI hype to highlight real-world applications already delivering value across research and development workflows. Topics include:
- AI – hype or a useful tool?
- AI for speed and usability: Low-Code/No-Code solutions
- FEP and AI: precision meets prediction
Why attend?
Whether you work in pharma, agrochemical research, academic science, or biotech innovation, this panel discussion will provide actionable insights into how AI can elevate your work beyond the hype.
Speakers
- Professor Julien Michel, Professor of Biomolecular Simulation, University of Edinburgh
- Dr Lewis Vidler, Senior Director of Structure Based Drug Design, Eli Lilly
- Dr Mark Mackey, Chief Scientific Officer, Cresset
- Dr. Mutlu Dogruel, VP of AI Solutions, Cresset